Metabolic Switching of Tumor Cells under Hypoxic Conditions in a Tumor-on-a-chip Model

Palacio-Castaneda Valentina*, Lucas Johannes Kooijman, Bastien Venzac, Verdurmen Wouter, Severine le Gac

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

32 Citations (Scopus)
95 Downloads (Pure)


Hypoxia switches the metabolism of tumor cells and induces drug resistance. Currently, no therapeutic exists that effectively and specifically targets hypoxic cells in tumors. Development of such therapeutics critically depends on the availability of in vitro models that accurately recapitulate hypoxia as found in the tumor microenvironment. Here, we report on the design and validation of an easy-to-fabricate tumor-on-a-chip microfluidic platform that robustly emulates the hypoxic tumor microenvironment. The tumor-on-a-chip model consists of a central chamber for 3D tumor cell culture and two side channels for medium perfusion. The microfluidic device is fabricated from polydimethylsiloxane (PDMS), and oxygen diffusion in the device is blocked by an embedded sheet of polymethyl methacrylate (PMMA). Hypoxia was confirmed using oxygen-sensitive probes and the effect on the 3D tumor cell culture investigated by a pH-sensitive dual-labeled fluorescent dextran and a fluorescently labeled glucose analogue. In contrast to control devices without PMMA, PMMA-containing devices gave rise to decreases in oxygen and pH levels as well as an increased consumption of glucose after two days of culture, indicating a rapid metabolic switch of the tumor cells under hypoxic conditions towards increased glycolysis. This platform will open new avenues for testing anti-cancer therapies targeting hypoxic areas
Original languageEnglish
Article number382
Issue number4
Publication statusPublished - 4 Apr 2020


  • UT-Gold-D


Dive into the research topics of 'Metabolic Switching of Tumor Cells under Hypoxic Conditions in a Tumor-on-a-chip Model'. Together they form a unique fingerprint.

Cite this